Nutanix (NTNX) PT Raised to $60 at Northland Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Wall Street stocks mixed on higher Treasury yields, rate expectations
- Powell says recent inflation data point to need to keep rates higher for longer
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- Bank of America profit hurt by losses on credit cards, office loans
- Morgan Stanley (MS) earnings beat lifts stock
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
Nutanix (NTNX) Stock is Rallying Following Q3 Earnings, Analyst Says Shares Still Looks Undervalued
November 24, 2021 8:59 AM ESTShares of Nutanix (NASDAQ: NTNX) are up more than 5% in pre-open Wednesday after the company reported better-than-expected Q3 results.
Nutanix reported Q1 EPS of ($0.22) to easily top the analyst estimate of ($0.34). Revenue for the quarter came in at $378.5 million versus the consensus estimate of $367.04 million.
Our first quarter was a good start to our fiscal year, demonstrating strong year-over-year top and bottom-line improvement, said Rajiv Ramaswami, President and CEO of Nutanix. We continued to execute... More
